Legal Representation
Attorney
Shauna M. Wertheim
USPTO Deadlines
Next Deadline
1927 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250408)
Due Date
April 08, 2031
Grace Period Ends
October 08, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 8, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 8, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 28, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 21, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 21, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 21, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 22, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Oct 22, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jul 24, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 24, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 24, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 18, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 18, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 3, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; pharmaceutical preparation, namely, an opioid antagonist; nasal sprays for treating opioid overdoses
First Use Anywhere:
Oct 11, 2023
First Use in Commerce:
Oct 11, 2023
Class 044
Medical services; health care; medical clinic services; provision of pharmaceutical advice and information about pharmaceuticals used in the treatment and prevention of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment and prevention of co-morbidities associated with substance use disorders, for the treatment and prevention of mental health diseases and disorders, for the treatment and prevention of central nervous system disease and disorders, and for the treatment of pain; health counseling; provision of health care information and advice; provision of information and advice relating to the diagnostic, prophylactic and therapeutic properties of pharmaceuticals
First Use Anywhere:
Oct 11, 2023
First Use in Commerce:
Oct 11, 2023
Additional Information
Design Mark
The mark consists of the term OPVEE centered below a stylized drawing of a sunrise comprised of straight lines.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
044